Navigation Links
Next Generation Pharmaceutical Manufacturing Summit Pushes the Envelope of Thought-Leadership at its September Summit in London
Date:5/31/2012

LONDON, May 31, 2012 /PRNewswire/ --

When it comes to the evolving arena of pharmaceutical manufacturing, there are few events that can match the precedence of GDS International's Next Generation Pharmaceutical (NGP) Manufacturing Summit: http://www.ngpharmaeurope.com

Always disruptive in its thought-leadership, this year's NGP Manufacturing summit will be hosted on the 17-19 September at the Radisson Edwardian Heathrow Hotel in London, UK - playing host to a 65-strong consortium of C-level executives and corporate officers from the region's most innovation and leading-edge pharmaceutical manufacturing firms. Positioned at the very pinnacle of industry movements, this year's summit promises to continue its trend as the most well respected event within the European Pharmaceutical industry.

Top C-level executives will be present to discuss cutting-edge business challenges, ranging from Operational Excellence and supply chain movements to regulatory impacts and traceability elements to name but a select few.

The Summit combines high-level roundtable discussions with next generation solutions that, together with the UK's Delegate Director, Francesca Swain, have been championed by the Summit's very own NG20 - populated with the industry's best-in-class thought-leaders - who have helped play a pivotal part in shaping the Summit's two-and-a-half day agenda and trends.

Included within the senior executive delegation are Olivier Rowland, EMEA Procurement Director at Merck Sharpe & Dhome; Merck's CISO, Frank Wagner; Regi Van Genechten, Senior Director of Supply Chain, Johnson & Johnson; Ingo Ebeling, Head of Technology & Product Support, Abbot Laboratories; and Novartis' Global Head of Purchasing IT, Philippe Gerwill.

Fabrizio Borin, Head of Production at Lundbeck Pharmaceuticals Italy, who attended the last NGP Manufacturing Summit at the Fairmont Le Montreux Palace, Switzerland, said: "It's a good, relaxed environment in which we have a chance to talk together, exchange ideas and create networks. A very good experience."

The event has been designed specifically for forward-thinking, C-level executives in the European Pharmaceutical manufacturing arena, drawing on experiences and discussing the challenges facing the sector. The NGP Manufacturing Summit will offer comprehensive, one-to-one meetings to give delegates the opportunity to meet with business analysts and solution providers to discuss strategy and technology demands in a rapidly evolving business climate.

Francesca Swain, GDS International's UK Delegate Director, believes the high calibre of speakers and exceptional content, combined with excellent networking opportunities, give the delegates and sponsors true value for money and a significant return on their investment.

"With just under four months until Europe's most significant Pharmaceutical Manufacturing Summit, we are delighted to announce the introduction of the NG20, which will ensure delegates receive a personal and relevant programme aimed at the highest level. We are pleased to be bringing together the top European pharmaceutical companies in one location at the same time.

"Key level executives will be in attendance, maximising every opportunity over the two-and-a-half days - and London will be a fantastic location to thrash out the current challenges facing the industry today. This is an exciting time for the European region, with the opportunity to shape the future of pharmaceutical manufacturing there for the taking."

For more information, please visit: http://www.ngpharmaeurope.com

About GDS International

GDS International is one of the most innovative events and media companies worldwide - and a globally renowned producer of business-to-business summits, conferences, online information and advisory group gatherings. Founded in 1993, GDS International specialises in meeting the B2B marketing needs of our clients. Having a strong presence in mature industrial sectors but a finger on the pulse of emerging markets - as well as up-and-coming B2B business verticals - means we are perfectly placed to capitalise on the exciting developments brought about by the advent of a globalised economy. Our value proposition is simple: we deliver tangible business results from world-class events.

http://www.gdsinternational.com

Contact: Rachel Sandeman
rachel.sandeman@gdsinternational.com
+44(0)1179-261-421



'/>"/>
SOURCE GDS International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. COPD Tops Asthma as the Focus Indication for Next Generation Respiratory Therapies at the 2012 American Thoracic Society Conference
2. MicuRx Pharmaceuticals Announces Issuance Of U.S. Patent For Its Next-Generation Antibacterial Agent
3. HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs Second Generation HIV Vaccine
4. Rubicon Genomics Launches ThruPLEX™ Family of Sample Preparation Products for Next Generation Sequencing Applications
5. Remedy Informatics to Debut SpecimenTrack, Next-Generation Biorepository Software at ISBER 2012 Annual Meeting
6. Rapid Fire Marketing Funds Development of Second Generation Vapor Inhaler
7. Life Technologies to Accelerate Adoption of Next-Generation Sequencing in HLA Through Key Partnerships
8. Genalyte, Inc. Completes $12 Million Series B Financing to Commercialize Its Maverick™ Next-Generation Multiplexing Platform
9. Awards for Drug Discovery Research for Frontotemporal Degeneration Announced
10. Isis Initiates Phase 1 Study in Patients With Cancer With the First Generation 2.5 Antisense Drug, ISIS-STAT3Rx
11. Stryker Launches Next Generation Heavy Duty Surgical Power Tools
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology:
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... ... 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland ... iHire in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness ... & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
Breaking Medicine News(10 mins):